Notification about latest news from us.
Trump's new deal with Pfizer aims to cut drug prices and launch TrumpRx for direct-to-consumer sales, promoting economic benefits.
The EU court's ruling opens up inquiries into Ursula von der Leyen’s communication with Pfizer, marking a significant win for transparency.
Major drug companies plan to raise prices on over 250 medications in the U.S., effective January 1, 2025, with median increases around 4.5%.
New research connects Depo-Provera to heightened meningioma risk, prompting legal scrutiny and raising concerns over contraceptive safety.
By clicking send you'll receive occasional emails from newsletters about this topic.